Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer: Comparison with urinary cytology and BTA test

European Urology

Volumn 35, Issue 2, 1999, Pages 93-97

  Del Nero, A ^a   Esposito, N ^a   Curro, A ^a   Biasoni, D ^a   Montanari, E ^a   Mangiarotti, B ^a   Trinchieri, A ^a   Zanetti, G ^a   Serrago, M P ^a   Pisani, E ^a  

^a Istituto di Urologia   (Italy)

Author keywords

Bladder cancer; Bladder tumor antigen; Cytology; NMP22; Urine marker

Indexed keywords

CELL MARKER; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER TUMOR; CANCER STAGING; CANCER TEST; CELL NUCLEUS MATRIX; COMPARATIVE STUDY; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA; URINALYSIS; URINE CYTOLOGY; URINE LEVEL;

ADULT; AGED; ANTIGENS, NEOPLASM; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; URINE;

EID: 0033066148     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000019825     Document Type: Article

References (15)